Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06607276 ×

NCT06607276

This funder is selected. Its supporting articles are shown below.

NCT066072761

Articles mentioning NCT06607276

1 articles · page 1 of 1

Adebrelimab plus capecitabine versus capecitabine monotherapy for adjuvant treatment of high-risk resected cholangiocarcinoma (ACHIEVE): protocol for a phase II, multicentre, randomised controlled trial

bmjgast · abstract · 2025-07-30 · 1 matching annotations

80.7%

NCT06607276 Capecitabine Immunotherapy Cholangiocarcinoma adebrelimab CCA

…d presented at scientific conferences.Trial registration number NCT06607276.…